Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

OBJECTIVE: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect of TKIs on allo-HSCT in CML. MATERIALS AND METHODS: In this quasi-experimental st...

Descripción completa

Detalles Bibliográficos
Autores principales: Özen, Mehmet, Üstün, Celalettin, Öztürk, Bengi, Topçuoğlu, Pervin, Arat, Mutlu, Gündüz, Mehmet, Atilla, Erden, Bolat, Gülşen, Arslan, Önder, Demirer, Taner, Akan, Hamdi, İlhan, Osman, Beksaç, Meral, Gürman, Günhan, Özcan, Muhit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451684/
https://www.ncbi.nlm.nih.gov/pubmed/27094579
http://dx.doi.org/10.4274/tjh.2015.0346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451684/
https://www.ncbi.nlm.nih.gov/pubmed/27094579
http://dx.doi.org/10.4274/tjh.2015.0346

Ejemplares similares